rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1998-8-14
|
pubmed:abstractText |
The benefits and the current indications of aprotinin in congenital operations are not well defined. At present there are only a few studies available that have investigated a small number of patients in several heterogeneous groups of malformations.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0003-4975
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
66
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
153-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9692456-Anesthesia, General,
pubmed-meshheading:9692456-Aprotinin,
pubmed-meshheading:9692456-Blood Coagulation,
pubmed-meshheading:9692456-Blood Loss, Surgical,
pubmed-meshheading:9692456-Blood Transfusion,
pubmed-meshheading:9692456-Cardiopulmonary Bypass,
pubmed-meshheading:9692456-Dose-Response Relationship, Drug,
pubmed-meshheading:9692456-Fibrin Fibrinogen Degradation Products,
pubmed-meshheading:9692456-Heart Defects, Congenital,
pubmed-meshheading:9692456-Heart Septal Defects, Ventricular,
pubmed-meshheading:9692456-Hemostatics,
pubmed-meshheading:9692456-Humans,
pubmed-meshheading:9692456-Infant,
pubmed-meshheading:9692456-Infant, Newborn,
pubmed-meshheading:9692456-Infusions, Intravenous,
pubmed-meshheading:9692456-Platelet Count,
pubmed-meshheading:9692456-Safety,
pubmed-meshheading:9692456-Tetralogy of Fallot,
pubmed-meshheading:9692456-Transposition of Great Vessels
|
pubmed:year |
1998
|
pubmed:articleTitle |
Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only.
|
pubmed:affiliation |
Clinic for Cardiovascular Surgery, University Hospital, Zürich, Switzerland. thierry.carrel@insel.ch
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study
|